The Clinical Pharmacokinetics and Pharmacodynamics of Warfarin When Combined with Compound Danshen: A Case Study for Combined Treatment of Coronary Heart Diseases with Atrial Fibrillation

Warfarin is used as anticoagulant and Compound Danshen prescription (CDP) is able to promote blood circulation. The combination might produce a synergic effect for patients of coronary heart diseases (CHDs) with atrial fibrillation (AF). Whether the combination increases the bleeding risk of warfari...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Pharmacol
Hlavní autoři: Lv, Chunxiao, Liu, Changxiao, Yao, Zhuhua, Gao, Xiumei, Sun, Lanjun, Liu, Jia, Song, Haibo, Li, Ziqiang, Du, Xi, Sun, Jinxia, Li, Yanfen, Ye, Kui, Wang, Ruihua, Huang, Yuhong
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2017
Témata:
Pharmacology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5702344/
https://ncbi.nlm.nih.gov/pubmed/29209208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00826
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky